<!DOCTYPE html><html><head><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,b,c){c=void 0!=c?c:(new Date).getTime();this.t[a]=[c,b]};this.tick("start",null,a)}var a=new e;window.jstiming={Timer:e,load:a};if(window.performance&&window.performance.timing){var b=window.performance.timing,a=window.jstiming.load,d=b.navigationStart,b=b.responseStart;0<d&&b>=d&&(a.tick("_wtsrt",void 0,d),a.tick("wtsrt_","_wtsrt",b))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT)),null==a&&window.gtbExternal&&
(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT),a&&(window.jstiming.pt=a)}catch(f){}})();})();
</script><title>AcelRx Pharmaceuticals Inc: NASDAQ:ACRX quotes & news - Google Finance</title><meta name="Description" content="Get detailed financial information on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) including real-time stock quotes, historical charts & financial news, all for free!"><link rel="canonical" href="http://www.google.com/finance?cid=9390385"><link rel="stylesheet" type="text/css" href="/finance/f/finance_us-3733104419.css"><link rel="stylesheet" type="text/css" href="/finance/_/ss/a/ver=1mhxyxuiwj38f/am=!jj9byiqA_OSUr8Z3/bf=/r=O"><link rel="icon" type="image/vnd.microsoft.icon" href="/finance/favicon.ico"><style>#gbar,#guser{font-size:13px;padding-right:8px;padding-top:4px !important;}#gbar{padding-left:8px;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}@media all{.gb1{height:22px;margin-right:.5em;vertical-align:top}#gbar{float:left}}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb4{color:#00c !important}.gbi .gb4{color:#dd8e27 !important}.gbf .gb4{color:#900 !important}</style><script></script><script>
      function _rpt() {}
      function _tck() {}
    </script></head><body><div class=fjfe-bodywrapper><div id=fjfe-real-body class=g-doc><input type="text" name="hist_state" id="hist_state" style="display:none;"><iframe id="hist_frame" name="hist_frame" class=invfr tabindex="-1"></iframe><iframe src="/finance/_/js/a/b/rt=h/ver=qNG2-4Cp47I.en_US./sv=1/am=!jj9byiqA_OSUr8Z3/d=0" class=invfr tabindex="-1"></iframe><div id=gbar><nobr><a class=gb1 href="http://www.google.com/webhp?hl=en&tab=ew">Search</a> <a class=gb1 href="http://www.google.com/imghp?hl=en&tab=ei">Images</a> <a class=gb1 href="http://video.google.com/?hl=en&tab=ev">Videos</a> <a class=gb1 href="http://maps.google.com/maps?hl=en&tab=el">Maps</a> <a class=gb1 href="http://news.google.com/nwshp?hl=en&tab=en">News</a> <a class=gb1 href="http://www.google.com/shopping?hl=en&tab=ef">Shopping</a> <a class=gb1 href="https://mail.google.com/mail/?tab=em">Gmail</a> <a class=gb1 style="text-decoration:none" href="http://www.google.com/intl/en/options/"><u>More</u> &raquo;</a></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a  href="http://www.google.com/support/finance?hl=en" class=gb4>Help</a> | <a target=_top id=gb_70 href="https://www.google.com/accounts/ServiceLogin?service=finance&passive=1209600&continue=http://www.google.com/finance?q%3DACRX&followup=http://www.google.com/finance?q%3DACRX" class=gb4>Sign in</a></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div id=fjfe-click-wrapper><script>
(function() {
  var l = window.location;
  var q = l.search ? l.search.substr(1) : '';
  var h = l.hash ? l.hash.substr(1) : '';
  var p = '/finance';
  var ss = 'stockscreener';
  var conn = window.history && window.history.pushState ? '/' : '#';
  if (l.pathname == p + '/' + ss) {
    if (h) l.href = p + conn + ss + '?' + q + '&' + h;
  } else if (l.pathname != p && h) {
    l.href = p + l.hash;
  }
  if (h) {
document.getElementById('fjfe-click-wrapper').style.display = 'none';
  }
})();
</script><div id=gf-head class="g-section g-tpl-75-25 g-split"><div class="g-unit g-first"><div class=fjfe-logo><a href="/finance/"><img src="/finance/f/logo_us-115376669.gif" alt="Google Finance"></a></div><div id=gf-search class=fjfe-search><form method="get" action="/finance" autocomplete="off"><input class=fjfe-searchbox-input name=q type=text tabindex=1 value="NASDAQ:ACRX"></input><span class=fjfe-searchbox-button-wrapper><span class=fjfe-searchbox-button-wrapper2><input class=fjfe-searchbox-button type=submit tabindex=2 value="Get quotes"></input></span></span></form></div></div><div class="g-unit fjfe-promo"><div id="ad-target2" class="id-ad-target2"></div></div></div><div class=elastic><div id=app class="g-section g-tpl-left-11p4em"><div class="g-unit g-first"><div id=gf-nav><div class=fjfe-nav-nav><ul class=fjfe-nav id=navmenu><li class="fjfe-nav-expanded fjfe-nav-selected">Company<li class=fjfe-nav-sub><div>Summary</div><li class=fjfe-nav-sub><a href="/finance/company_news?q=NASDAQ:ACRX">News</a><li class=fjfe-nav-sub><a href="/finance/related?q=NASDAQ:ACRX">Related companies</a><li class=fjfe-nav-sub><a href="/finance/historical?q=NASDAQ:ACRX">Historical prices</a><li class=fjfe-nav-sub><a href="/finance?q=NASDAQ:ACRX&fstype=ii">Financials</a><li class=fjfe-nav-item><a href="/finance"><div>Markets</div></a><li class=fjfe-nav-item><a href="/finance/market_news"><div>News</div></a><li class=fjfe-nav-item><a href="/finance/portfolio?action=view"><div>Portfolios</div></a><li class=fjfe-nav-item><a href="/finance/stockscreener"><div>Stock screener</div></a><li class=fjfe-nav-item><a href="/finance/domestic_trends"><div>Google Domestic Trends</div></a></ul></div><div class="fjfe-recentquotes fjfe-recentquotes-noquote"><h4>Recent Quotes</h4><div class=fjfe-recentquotes-noquote-notification>You have no recent quotes</div><div class=fjfe-recentquotes-quotes><div class="fjfe-toggle fjfe-toggle-button"><span class=fjfe-chg-toggle>chg</span> | <span class=fjfe-perc-toggle>%</span></div><div class=fjfe-table-div><table class=fjfe-recentquotes-table id=rq width=100%></table></div></div></div><div class=fjfe-nav-ra></div></div><script>var _cleardot = 'data:image/gif;base64,R0lGODlhAQABAIAAAP///////yH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==';
    var google = google || {};
    google.finance = google.finance || {};
    google.finance.enable_gviz_charts =false;</script><script src="/finance/f/sfe-opt-3465732731.js"></script><script>
      _regOnLoad = function(f) { f && f(); };
    
      google.finance.renderRecentActivities = function() {};
      google.finance.renderRecentQuotes = function() {};
    </script></div><div class=g-unit id=gf-viewc><div class=fjfe-content>
<script>
(function() {
if (window['_finance_chart']) {
var el = document.getElementById('chart_anchor');
if (el) {
el.innerHTML = '';
}
setFinanceChart(null);
}
})();
var _ticker = 'NASDAQ:ACRX';
var _slHeight = 221;
var _companyName = 'AcelRx Pharmaceuticals Inc';
var _displayVolume = true;
setCompanyId(9390385);
_s_Store._numToDisplay = 6;
_comparison_charts_Store._numToDisplay = 8;
_comparison_charts_Store._allowMultiTimezoneCompare = true;
function onCompanyLoad() {
_external_target = "";
_emitFlashChartOnLoad(
"/finance/s/ytAiJsp2Tzo/chart9.swf?hl=en&gl=us",
_ticker, "chart_anchor", "market-data-div",
_chartConfigObject);
google.finance.onCompanyLoad();
_initAutoFocus();
if (google.finance.initTechnicals) {
google.finance.initTechnicals(true);
}
}
</script>
<div class=g-wrap>
<div class="g-section sfe-break-bottom-8">
<div class="g-tpl-67-33 g-split hdg top appbar-hide" id=companyheader>
<div class="g-unit g-first"><h3>AcelRx Pharmaceuticals Inc&nbsp;&nbsp;</h3>(Public, NASDAQ:ACRX)&nbsp;&nbsp;
<a href="/finance/portfolio?action=add&amp;addticker=NASDAQ%3AACRX" class=norm>Watch this stock</a>
&nbsp;
</div><div class="g-unit norm">Find more results for<b>
<a href="?noIL=1&q=ACRX" id=searchmore>ACRX</a></b>
</div>
</div>
</div>

<div id=ra-src class=hide>
<div id=ra-target></div>
</div>
<script>
google.finance.renderRecentActivities();
_ac_register(function (input, event) {
if (input.id == 'add_comparison_symbol') {
_comparison_charts_Store.baseTicker = "NASDAQ:ACRX";
return _comparison_charts_Store;
}
});
var _prefs=_prefs||{};_prefs.hash="";
_prefs.feeds=_prefs.feeds||{};
_prefs.ch=_prefs.ch||{};
_prefs.ch_compare=_prefs.ch_compare||{};
var _chartConfigObject;
var _cleardot;
var _companyName;
var _eventid = null;
var _expid;
var _external_target;
var _minZoomDays;
var _minZoomDaysNoIntraDay;
var _prefs;
var _ticker;
var _urlSuffix;
var google = google || {};
google.finance = google.finance || {};
google.finance.data = {common:{rq:{ct:""},up:"chg",down:"chr",linktargetInternal:"",hash:"",dfp:"ad-g.doubleclick.net/adi/com.gf.company/healthcare;fe=nasdaq;ft=acrx;fm=small;dcopt=ist;myd=ad;ord=55953;sz=300x250;tile=1",streaming:[{cid:"9390385",s:"ACRX",e:"NASDAQ"},{cid:"707383",s:"CADX",e:"NASDAQ"},{cid:"714605",s:"NGSX",e:"NASDAQ"},{cid:"665323",s:"DRRX",e:"NASDAQ"},{cid:"671805",s:"BDSI",e:"NASDAQ"},{cid:"665002",s:"PTIE",e:"NASDAQ"},{cid:"721955",s:"OMER",e:"NASDAQ"},{cid:"665015",s:"ENDP",e:"NASDAQ"},{cid:"689769",s:"ANSVQ",e:"PINK"},{cid:"16552257",s:"PCRX",e:"NASDAQ"},{cid:"266634",s:"ACUR",e:"NASDAQ"}],dfp_companion:"ad-g.doubleclick.net/adi/com.gf.company/healthcare;fe=nasdaq;ft=acrx;fm=small;dcopt=ist;myd=ad;ord=55953;sz=33x33;tile=2"},company:{news:{clusters:[{nrel:10,idx:0,id:"35185784659798",lead_story_url:"http://www.biomedreports.com/2012062197863/dmc-committee-recommends-continued-enrollment-in-study-of-oncolytics-reolysinr-onyx-gets-positive-vote-for-kyprolis-by-odac.html",a:[{t:"DMC Committee Recommends Continued Enrollment in Study of \x3cb\x3e...\x3c/b\x3e",u:"http://www.biomedreports.com/2012062197863/dmc-committee-recommends-continued-enrollment-in-study-of-oncolytics-reolysinr-onyx-gets-positive-vote-for-kyprolis-by-odac.html",s:"BioMedReports (subscription)",sp:"Below is a look at some of the headlines for companies that made news in the healthcare sector on June 20, 2012. Oncolytics Biotech Inc. (NASDAQ:ONCY) ...",d:"45 minutes ago",tt:"1340238594"}],lead_story_doc_id:"11829889853616633658"},{nrel:13,idx:1,id:"35185784206590",lead_story_url:"http://www.sacbee.com/2012/06/20/4575591/acelrx-pharmaceuticals-receives.html",a:[{t:"AcelRx Pharmaceuticals Receives First U.S. Patent for Small \x3cb\x3e...\x3c/b\x3e",u:"http://www.sacbee.com/2012/06/20/4575591/acelrx-pharmaceuticals-receives.html",s:"Sacramento Bee",sp:"PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of ...",d:"12 hours ago",tt:"1340195417"},{t:"AcelRx Pharmaceuticals Receives First US Patent for Small-Volume \x3cb\x3e...\x3c/b\x3e",u:"http://www.marketwatch.com/story/acelrx-pharmaceuticals-receives-first-us-patent-for-small-volume-oral-transmucosal-dosage-forms-2012-06-20",s:"MarketWatch (press release)",sp:"REDWOOD CITY, Calif., June 20, 2012 /PRNewswire via COMTEX/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) , a specialty pharmaceutical company ...",d:"13 hours ago",tt:"1340191907"}],lead_story_doc_id:"12325853084623395506"},{idx:2,id:"0",lead_story_url:"http://www.biomedreports.com/2012062097773/acelrx-pharmaceuticals-receives-first-u-s-patent-for-small-volume-oral-transmucosal-dosage-forms.html",a:[{t:"AcelRx Pharmaceuticals Receives First US Patent for Small-Volume \x3cb\x3e...\x3c/b\x3e",u:"http://www.biomedreports.com/2012062097773/acelrx-pharmaceuticals-receives-first-u-s-patent-for-small-volume-oral-transmucosal-dosage-forms.html",s:"BioMedReports (subscription)",sp:"My news for Investors REDWOOD CITY, Calif. , June 20, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical ...",d:"13 hours ago",tt:"1340193825"}],lead_story_doc_id:"55391900575388164"},{idx:3,id:"0",lead_story_url:"http://zolmax.com/analysts-ratings-reiterations-for-june-18th-acrx-kr-mdrx-mela-phmd-schn-stld-teva-wpi-www/2912398/",a:[{t:"Analysts\x26#39; Ratings Reiterations for June, 18th (ACRX, KR, MDRX \x3cb\x3e...\x3c/b\x3e",u:"http://zolmax.com/analysts-ratings-reiterations-for-june-18th-acrx-kr-mdrx-mela-phmd-schn-stld-teva-wpi-www/2912398/",s:"Junction Report",sp:"stock ratings Analysts\x26#39; ratings reiterations for Monday, June 18th: AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) had its �buy� rating re-affirmed by analysts at ...",d:"Jun 18, 2012",tt:"1340032077"}],lead_story_doc_id:"12397756296644071760"},{idx:4,id:"2552165",tt:"1338809400",lead_story_url:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20120604113000",a:[{t:"AcelRx Pharmaceuticals Inc Completes Private Placement of $10.0 Million",u:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20120604113000",s:"Reuters Key Development",d:"Jun 4, 2012",tt:"1338809400"}],score:18},{idx:5,id:"2519532",tt:"1334230200",lead_story_url:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20120412113000",a:[{t:"AcelRx Pharmaceuticals Inc Announces Initiation Of Second Phase Three Clinical Trial For ARX-01",u:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20120412113000",s:"Reuters Key Development",d:"Apr 12, 2012",tt:"1334230200"}],score:2},{idx:6,id:"2518738",tt:"1334143800",lead_story_url:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20120411113000",a:[{t:"AcelRx Pharmaceuticals Inc Receives Two Notices Of Allowance For Small-Volume Oral Transmucosal Dosage Forms",u:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20120411113000",s:"Reuters Key Development",d:"Apr 11, 2012",tt:"1334143800"}],score:2},{idx:7,id:"2495672",tt:"1331080740",lead_story_url:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20120307003900",a:[{t:"AcelRx Pharmaceuticals Inc Announces Initiation Of Phase 3 Clinical Program For ARX-01, The Sufentanil NanoTab PCA System For The Treatment Of Post-Operative Pain",u:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20120307003900",s:"Reuters Key Development",d:"Mar 7, 2012",tt:"1331080740"}],score:2},{idx:8,id:"2355548",tt:"1309455000",lead_story_url:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20110630173000",a:[{t:"AcelRx Pharmaceuticals Inc Secures $20 Million Loan Financing Agreement",u:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20110630173000",s:"Reuters Key Development",d:"Jun 30, 2011",tt:"1309455000"}],score:2},{idx:9,id:"2332247",tt:"1297382400",lead_story_url:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20110211000000",a:[{t:"AcelRx Pharmaceuticals Inc Raises $40 Million Through Initial Public Offering-Datamonitor\x26#39;s Financial Deals Tracker",u:"http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66\x26symbol=ACRX.O\x26timestamp=20110211000000",s:"Reuters Key Development",d:"Feb 11, 2011",tt:"1297382400"}],score:18},{idx:10,id:"-1"}],results_per_page:10,result_start_num:1,result_end_num:0,result_total_articles:12},related:{cols:[0,1,4,30,34,31,32,5,2,33,3],rows:[{id:"9390385",values:["ACRX","AcelRx Pharmaceuticals Inc","2.90","0.00","chb","0.00","","57.11M","NASDAQ","9390385","ACRX"]},{id:"707383",values:["CADX","Cadence Pharmaceuticals, Inc.","2.91","+0.02","chg","0.69","","248.92M","NASDAQ","707383","CADX"]},{id:"714605",values:["NGSX","NeurogesX, Inc","0.324","-0.006","chr","-1.67","","10.77M","NASDAQ","714605","NGSX"]},{id:"665323",values:["DRRX","DURECT Corporation","0.820","-0.021","chr","-2.46","","71.84M","NASDAQ","665323","DRRX"]},{id:"671805",values:["BDSI","BioDelivery Sciences Intl., Inc.","3.88","+0.12","chg","3.19","","115.31M","NASDAQ","671805","BDSI"]},{id:"665002",values:["PTIE","Pain Therapeutics, Inc.","4.65","-0.12","chr","-2.52","","208.00M","NASDAQ","665002","PTIE"]},{id:"721955",values:["OMER","Omeros Corporation","12.97","-0.13","chr","-0.99","","291.20M","NASDAQ","721955","OMER"]},{id:"665015",values:["ENDP","Endo Health Solutions Inc","30.64","+0.49","chg","1.63","","3.59B","NASDAQ","665015","ENDP"]},{id:"689769",values:["ANSVQ","Anesiva, Inc.","0.0000","","","","","129,500.00","PINK","689769","ANSVQ"]},{id:"16552257",values:["PCRX","Pacira Pharmaceuticals Inc","15.21","+0.09","chg","0.60","","491.51M","NASDAQ","16552257","PCRX"]},{id:"266634",values:["ACUR","Acura Pharmaceuticals, Inc.","3.21","+0.14","chg","4.56","","147.21M","NASDAQ","266634","ACUR"]}],visible_cols:[0,1,4,30,34,31,32,5]},related_str:"9390385,707383,714605,665323,671805,665002,721955,665015,689769,16552257,266634",perf:[{u:"/finance?q=INDEXDJX:.DJI",name:"Dow Jones",cp:"-0.10",p:"12,824.39",cid:"983582"},{u:"/finance?q=INDEXNASDAQ:.IXIC",name:"Nasdaq",cp:"0.02",p:"2,930.45",cid:"13756934"},{u:"/finance?catid=us-64715132",name:"Healthcare",cp:"-0.03",cid:"0"},{u:"/finance?q=NASDAQ:ACRX",name:"ACRX",cp:"0.00",p:"2.90",cid:"9390385"}],t:"NASDAQ:ACRX: {LAST} {CHANGE} ({CHANGE_PCT}%) - AcelRx Pharmaceuticals Inc",ticker:"NASDAQ:ACRX",cid:"9390385"},stickyUrlArgs:"",chart:{_5d:"EXCHANGE%3DNASDAQ\nMARKET_OPEN_MINUTE=570\nMARKET_CLOSE_MINUTE=960\nINTERVAL=120\nCOLUMNS=DATE,CLOSE,VOLUME\nDATA=\nTIMEZONE_OFFSET=-240\na1339688880,3.1999,100\n8,3.14,2100\n12,3.1,1600\n123,3.15,100\n684,3.15,100\n717,3.15,893\n738,3,200\n739,3,200\n740,2.95,1283\n741,3,100\n742,2.95,500\n743,3,400\n744,2.9,608\n745,2.99,100\n746,2.85,913\n747,2.85,1000\n748,2.85,200\n749,2.85,1287\n750,3,300\n751,3,300\n752,3,100\n821,2.96,1000\n833,3,100\n846,3.04,119\na1340026320,2.94,100\n1,2.9,1300\n40,2.9,304\n116,2.9,100\n132,2.9,200\n134,2.9,200\n719,2.9,320\n914,2.9,0\n",_5Y:"EXCHANGE%3DNASDAQ\nMARKET_OPEN_MINUTE=570\nMARKET_CLOSE_MINUTE=960\nINTERVAL=604800\nCOLUMNS=DATE,CLOSE,VOLUME,CDAYS\nDATA=\nTIMEZONE_OFFSET=-300\na1297458000,4.55,1899648,5\n1,3.65,172996,5\n2,3.59,93686,4\n3,3.3,232776,5\n4,3.17,190877,5\nTIMEZONE_OFFSET=-240\na1300478400,3.12,52520,5\n1,3.47,141083,5\n2,3.38,44732,5\n3,3.22,49084,5\n4,3.15,26506,5\na1303416000,3.12,30534,5\na1304107200,3.42,49583,5\n1,3.43,41321,5\n2,3.5001,41865,5\n3,4.17,129689,5\n4,4.62,168871,5\n5,4.74,101259,4\n6,4.5,72720,5\n7,4.22,56853,5\n8,4.54,49302,5\n9,4.4,25440,5\n10,4.25,12470,4\n11,4.42,34867,5\n12,4.38,57130,5\n13,4.1,64576,5\n14,4.01,5400,5\n15,3.7,35313,5\n16,3.45,4700,5\n17,3.111,27379,5\n18,3.1,10679,5\n19,3.26,20325,4\n20,3.25,28563,5\n21,3.22,29632,5\n22,3.21,11910,5\n23,3.03,1911,5\n24,3,13264,5\n25,2.89,5875,5\n26,2.91,40380,5\n27,2.9015,1000,5\nTIMEZONE_OFFSET=-300\na1321045200,2.77,2600,5\n1,2.8701,109554,5\n2,2.9,6277,4\n3,2.85,50023,5\n4,2.7,3100,5\n5,2.7,7671,5\n6,2.1001,32840,5\n7,1.92,19621,4\n8,2.12,24138,4\n9,2.92,42772,5\n10,2.76,13105,4\n11,2.61,29818,5\n12,3.3,117616,5\n13,3.21,35676,5\n14,3,36075,5\n15,2.89,12725,4\n16,2.91,22639,5\n17,3.611,75366,5\nTIMEZONE_OFFSET=-240\na1331928000,3.55,13329,5\n1,3.4,40932,5\n2,3.49,10461,5\na1333656000,3.4,7700,5\na1334347200,3.25,30044,5\n1,3.39,8950,5\n2,3.8,26756,5\n3,3.8,33661,5\n4,3.52,12390,5\n5,3.6,17581,5\n6,3.53,6073,5\n7,3.2499,16597,4\n8,2.99,21773,5\n9,3.04,17793,5\n",corp_actions:"[]",related_items:[{ticker:"INDEXDJX:.DJI",name:"Dow Jones",timezone_offset:-18000,is_index:true,different_market_session:false},{ticker:"INDEXNASDAQ:.IXIC",name:"Nasdaq",timezone_offset:-18000,is_index:true,different_market_session:false},{ticker:"NASDAQ:CADX",name:"CADX",timezone_offset:-18000,is_index:false},{ticker:"NASDAQ:NGSX",name:"NGSX",timezone_offset:-18000,is_index:false},{ticker:"NASDAQ:DRRX",name:"DRRX",timezone_offset:-18000,is_index:false},{ticker:"NASDAQ:BDSI",name:"BDSI",timezone_offset:-18000,is_index:false},{ticker:"NASDAQ:PTIE",name:"PTIE",timezone_offset:-18000,is_index:false},{ticker:"NASDAQ:OMER",name:"OMER",timezone_offset:-18000,is_index:false},{ticker:"NASDAQ:ENDP",name:"ENDP",timezone_offset:-18000,is_index:false}]}};
google.finance.data.numberFormat = [{'threshold':1000000, 'symbol':'M'}, {'threshold':1000000000,'symbol':'B'}, {'threshold':1000000000000,'symbol':'T'}] ;
_setStickyUrlParams("");
if (_s_Store) {
_s_Store._allowMatchAdvancedSearch = true;
var _fieldToDisplayNameMap = {GrossMargin:"Gross margin&nbsp;(%)",Return1Week:"1w return",Return156Week:"156w return",NextYearEPS:"Next year EPS",LTDebtToAssetsYear:"LT debt/assets (Recent&nbsp;yr)&nbsp;(%)",RevenueGrowthRate5Years:"5y revenue growth rate",EarningsAfterTaxes:"Earnings after taxes",DividendPerShare:"Div per share",MarketCap:"Market cap",NetProfitMarginPercent:"Net profit margin&nbsp;(%)",Float:"Float",EarningsBeforeTaxes:"Earnings before taxes",QuotePercChange:"Quote change&nbsp;(%)",TotalDebtToEquityYear:"Total debt/equity (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToCapitalQuarter:"Total debt/capital (Recent&nbsp;qtr)&nbsp;(%)",LTDebtToCapitalQuarter:"LT debt/capital (Recent&nbsp;qtr)&nbsp;(%)",EPSGrowthRate10Years:"10y EPS growth rate",Beta:"Beta",ReturnOnAssetsPTM:"Return on assets (PTM)&nbsp;(%)",CapitalGain:"Capital gain",BetaDown:"Beta down from RAS",IncomeDividend:"Income dividend",RevenueGrowthRate10Years:"10y revenue growth rate",MarketCapShareBasis:"Market cap share basis",IAD:"Div rate indicated annual",Return4Week:"4w return",Price150DayAverage:"150d avg price",EPSGrowthRate5Years:"5y EPS growth rate",ReturnOnAssetsTTM:"Return on assets (TTM)&nbsp;(%)",TotalDebtToAssetsYear:"Total debt/assets (Recent&nbsp;yr)&nbsp;(%)",Volume:"Volume",DividendRecentQuarter:"Div recent quarter",CurrentRatioYear:"Current ratio",Low52Week:"52w low",ExpenseRatio:"Expense ratio",Price13WeekPercChange:"13w&nbsp;price change&nbsp;(%)",Price1DayPercChange:"1d&nbsp;price change&nbsp;(%)",ReturnOnEquity5Years:"Return on equity (5&nbsp;yr&nbsp;avg)&nbsp;(%)",TotalDebtToCapitalYear:"Total debt/capital (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToAssetsQuarter:"Total debt/assets (Recent&nbsp;qtr)&nbsp;(%)",NavChange:"Nav change",OperatingMargin:"Operating margin&nbsp;(%)",DPSRecentYear:"Div per share (Recent&nbsp;yr)",ANI:"Earnings after taxes (Recent&nbsp;yr)",AverageVolume:"Average volume",High52Week:"52w high",Return13Week:"13w return",PriceToCashFlowPerShare:"Price to cash flow per share",ATAXRATE:"Tax rate (Recent&nbsp;yr)",Price26WeekPercChange:"26w&nbsp;price change&nbsp;(%)",QuoteChange:"Quote change",NetIncomeChangePerc:"Net income change&nbsp;(%)",ReturnOnInvestment5Years:"Return on investment (5&nbsp;yr&nbsp;avg)&nbsp;(%)",PE:"P/E ratio",ReturnOnInvestmentYear:"Return on investment (Recent&nbsp;yr)&nbsp;(%)",Price200DayAverage:"200d avg price",DividendNextQuarter:"Div next quarter",EBITD:"EBITDA",PriceYTDPercChange:"YTD&nbsp;price change&nbsp;(%)",ReturnOnInvestmentTTM:"Return on investment (TTM)&nbsp;(%)",NavChangePercent:"Nav change&nbsp;(%)",EBITDMargin:"EBITDA margin&nbsp;(%)",LTDebtToEquityQuarter:"LT debt/equity (Recent&nbsp;qtr)&nbsp;(%)",BetaRAS:"Beta from RAS",PriceSales:"Price to sales",NetAssets:"Net assets",ReturnOnEquityTTM:"Return on equity (TTM)&nbsp;(%)",CashPerShareYear:"Cash/share",ReturnOnAssets5Years:"Return on assets (5&nbsp;yr&nbsp;avg)&nbsp;(%)",ReturnDay:"1d return",Return52Week:"52w return",ForwardPE1Year:"1y fwd P/E",NetIncomeGrowthRate5Years:"5y net income growth rate",DividendYield:"Div yield&nbsp;(%)",Dividend:"Div from cash flow",BetaUp:"Beta up from RAS",LTDebtToCapitalYear:"LT debt/capital (Recent&nbsp;yr)&nbsp;(%)",nprice:"Price from RAS",Return260Week:"260w return",ReturnOnEquityQuarter:"Return on equity (Recent&nbsp;qtr)&nbsp;(%)",ACOGS:"Cost of goods sold",LTDebtToAssetsQuarter:"LT debt/assets (Recent&nbsp;qtr)&nbsp;(%)",PriceToBook:"Price to book",LTDebtToEquityYear:"LT debt/equity (Recent&nbsp;yr)&nbsp;(%)",ReturnYTD:"Return YTD",ReturnOnEquityYear:"Return on equity (Recent&nbsp;yr)&nbsp;(%)",ReturnOnAssetsQuarter:"Return on assets (Recent&nbsp;qtr)&nbsp;(%)",TotalDebtToEquityQuarter:"Total debt/equity (Recent&nbsp;qtr)&nbsp;(%)",NavPrior:"Nav prior",AINTCOV:"Interest coverage",EPS:"EPS",ReturnOnInvestmentQuarter:"Return on investment (Recent&nbsp;qtr)&nbsp;(%)",QuoteLast:"Last price",Price50DayAverage:"50d avg price",Price4WeekPercChange:"4w&nbsp;price change&nbsp;(%)",ReturnOnAssetsYear:"Return on assets (Recent&nbsp;yr)&nbsp;(%)",MarketCapRAS:"Mkt cap from RAS",Price52WeekPercChange:"52w&nbsp;price change&nbsp;(%)",ShortInterestRatioPercent:"Short interest ratio&nbsp;(%)",InstitutionalPercentHeld:"Institutional percent held",BookValuePerShareYear:"Book value/share",ReturnOnEquityPTM:"Return on equity (PTM)&nbsp;(%)"};
_s_Store._asStore._addStrings(_fieldToDisplayNameMap);
}
if (_s_Store) {
_s_Store._allowMultipleInBox = true;
}
google.finance.renderRecentQuotes();
</script>
<div class="g-section g-tpl-right-1">
<div class="g-unit g-first">
<div class=g-c>
<div id=r-perf class="g-section g-tpl-67-33 g-split nwp">
<div id=r-perf-quotes class="id-r-perf-quotes g-unit g-first"></div>
<div id=r-perf-charts class="id-r-perf-charts g-unit"></div>
</div>
<script>google.finance.renderRelativePerformance();</script>
</div>
</div>
<div class=g-unit>
<div id=market-data-div class="id-market-data-div nwp g-floatfix">
<div id=price-panel class="id-price-panel goog-inline-block">
<div>
<span class="pr">
<span id="ref_9390385_l">2.90</span>
</span>
<div class="id-price-change nwp">
<span class="ch bld"><span class="chb" id="ref_9390385_c">0.00</span>
<span class="chb" id="ref_9390385_cp">(0.00%)</span>
</span>
</div>
</div>
<div>
<span class=nwp>
Jun 19 - Close
</span>
<div class=mdata-dis>
<span class=dis-large><nobr>NASDAQ
real-time data -
<a href="http://www.google.com/help/stock_disclaimer.html#realtime"  class=dis-large>Disclaimer</a>
</nobr></span>
<div>Currency in USD</div>
</div>
</div>
</div>
<div class="snap-panel-and-plusone">
<div class="snap-panel">
<table class="snap-data">
<tr>
<td class="key"
          data-snapfield="range">Range
</td>
<td class="val">&nbsp;&nbsp;&nbsp;&nbsp;-
</td>
</tr>
<tr>
<td class="key"
          data-snapfield="range_52week">52 week
</td>
<td class="val">1.76 - 4.74
</td>
</tr>
<tr>
<td class="key"
          data-snapfield="open">Open
</td>
<td class="val">&nbsp;&nbsp;&nbsp;&nbsp;-
</td>
</tr>
<tr>
<td class="key"
          data-snapfield="vol_and_avg">Vol / Avg.
</td>
<td class="val">0.00/3,070.00
</td>
</tr>
<tr>
<td class="key"
          data-snapfield="market_cap">Mkt cap
</td>
<td class="val">57.11M
</td>
</tr>
<tr>
<td class="key"
          data-snapfield="pe_ratio">P/E
</td>
<td class="val">&nbsp;&nbsp;&nbsp;&nbsp;-
</td>
</tr></table><table class="snap-data">
<tr>
<td class="key"
          data-snapfield="latest_dividend-dividend_yield">Div/yield
</td>
<td class="val">&nbsp;&nbsp;&nbsp;&nbsp;-
</td>
</tr>
<tr>
<td class="key"
          data-snapfield="eps">EPS
</td>
<td class="val">-1.48
</td>
</tr>
<tr>
<td class="key"
          data-snapfield="shares">Shares
</td>
<td class="val">19.69M
</td>
</tr>
<tr>
<td class="key"
          data-snapfield="beta">Beta
</td>
<td class="val">&nbsp;&nbsp;&nbsp;&nbsp;-
</td>
</tr>
<tr>
<td class="key"
          data-snapfield="inst_own">Inst. own
</td>
<td class="val">42%
</td>
</tr>
</table>
</div>
<div class="plusone-box" id="plusone-box">
<g:plusone size="standard" source="google:FINANCE"></g:plusone></div>
</div>
</div>
<script>google.finance.renderMarketData();</script>
</div>
</div>
<div class="g-section g-tpl-right-1 sfe-break-top-5">
<div class="g-unit g-first">
<div class=g-c><div>
<div id=newstabsgroup>
<div id=news-tabs class="id-news-tabs hide">
<div class="goog-tab goog-tab-selected"><a id=news_tab_title class=t>
<b class=t><b class=t>News</b></b></a></div>
<div class=goog-tab><a id=blogs_tab_title class=t>
<b class=t><b class=t>Blogs</b></b></a></div>
<div class=goog-tab><a id=plot_feeds_title class=t>
<b class=t><b class=t>Feeds</b></b></a></div>
</div>
<div id=tabs-clear class="id-tabs-clear goog-tab-bar-clear hide"></div>
<div id=news_div_cont class=id-news_div_cont style="display:none"></div>
<div id=blogs_div_cont class=id-blogs_div_cont style="display:none"></div>
<div id=plot_feed_div_cont class=id-plot_feed_div_cont style="display:none">
</div>
</div>
<div class="sfe-section clf" id=news-footer>
<div id=news-sidebar-footer class="g-section g-tpl-67-33 g-split">
<div class="g-unit g-first">
<a href="/finance/company_news?q=NASDAQ:ACRX" >All news for AcelRx Pharmaceuticals Inc &raquo;</a>
</div><div class=g-unit>
<a href="/finance/company_news?q=NASDAQ:ACRX&output=rss">Subscribe</a>
<a href="/finance/company_news?q=NASDAQ:ACRX&output=rss"><img class=SP_subscribe src="/finance/s/m4C5KaofCbA/images/cleardot.gif" alt="Subscribe." id=rss
        width=15 height=15 /></a>
</div>
</div>
</div>
</div>
<div id=ad class="sfe-break-top sfe-break-bottom-16">
<div id=ad-label
                       class="id-ad-label invisible">Advertisement</div>
<div id=ad-target class="id-ad-target ads-300-250"></div>
</div>
<div class="g-section g-tpl-25-75 g-split hdg">
<div class="g-unit g-first">
<h3>Events</h3>
</div>
<div class="g-unit">
<div class=sfe-break-right-em>
<img src="/finance/s/m4C5KaofCbA/images/cleardot.gif"
               width=16 height=16 class=SP_calendar id=calendar alt="">
<a onclick="_GF_click('', 'add_ical', 'ACRX', '')" href="http://www.google.com/calendar/render?hl=en&cid=http://www.google.com:80%2Ffinance%2Fevents%3Fq%3DNASDAQ%3AACRX%26output%3Dical" >Add ACRX to my calendars</a>
</div>
</div>
</div>
<div class="events sfe-section">
<div class=event>
<div class="bld date">Jun 7, 2012</div>
<div>AcelRx Pharmaceuticals, Inc. at Jefferies Global Healthcare Conference
</div>
</div>
<table><tr>
<td>
<a href="http://www.dailyfinance.com/event/ACRX/usa" >
More events from DailyFinance &raquo;</a>&nbsp;
&nbsp;&nbsp;<nobr>
</td>
</tr></table>
</div>
<div class=hdg><h3>Key stats and ratios</h3></div>
<div class=sfe-section>
<table class="quotes rgt nwp" width="100%">
<thead><tr>
<td width=50%>
<td class=colHeader>Q1 (Mar &#39;12)
<td class=colHeader>2011
</tr></thead>
<tr>
<td class="lft name">Net profit margin
<td class=period>-2147.42%
<td class=period>-1875.09%
<tr>
<td class="lft name">Operating margin
<td class=period>-1989.67%
<td class=period>-1805.22%
<tr>
<td class="lft name">EBITD margin
<td class=period>-
<td class=period>-1757.37%
<tr>
<td class="lft name">Return on average assets
<td class=period>-75.74%
<td class=period>-84.34%
<tr>
<td class="lft name">Return on average equity
<td class=period>-198.87%
<td class=period>-
<tr>
<td class="lft name">Employees
<td class=period>21
<td class=period>-
<tr>
<td class="lft name">Carbon Disclosure Rating
<td class=period>-
<td class=period>
-
</table>
<div class=sfe-break-top>
<a id="similar" href="/finance/similar?q=NASDAQ:ACRX" >Screen stocks with similar metrics &raquo;</a></div>
</div>
<div class=hdg><h3>Address</h3></div>
<div class=sfe-section>351 Galveston Drive<br/>REDWOOD CITY, CA 94063<br/>United States
- <a href="http://maps.google.com/maps?q=351+Galveston+Drive+REDWOOD+CITY+94063+United+States%20(AcelRx+Pharmaceuticals+Inc)" >Map</a><br/>+1-650-2163500 (Phone)<br>+1-650-2166500 (Fax)<br>
</div>
<div class=hdg><h3>Website links</h3></div>
<div class=sfe-section><div class=item>
<a id=fs-chome href="http://www.acelrx.com/" >
http://www.acelrx.com/
</a>
</div>
<div class=item><a id=fs- href="http://news.acelrx.com/phoenix.zhtml?c=241441&p=irol-acelrxnews&nyo=0" >News Releases</a></div>
<div class=item><a id=fs- href="http://ir.acelrx.com/phoenix.zhtml?c=241441&p=irol-irhome" >Investor Relations</a></div>
<div class=item><a id=fs- href="http://ir.acelrx.com/phoenix.zhtml?c=241441&p=irol-sec" >Financial Information</a></div>
<div class=item><a id=fs- href="http://www.acelrx.com/about/overview.html" >Corporate History/Profile</a></div>
<div class=item><a id=fs- href="http://www.acelrx.com/about/management.html" >Executives</a></div>
<div class=item><a id=fs- href="http://www.acelrx.com/pipeline/index.html" >Products/Services</a></div>
</div>
<div class=hdg><h3>External links</h3></div>
<div class=sfe-section>
<div class=item><a id=m-analyst
                 href=http://www.marketwatch.com/tools/quotes/snapshot.asp?symb=ACRX&pg=analyst >Analyst Estimates</a> - <font color="#6F6F6F">MarketWatch</font></div>
<div class=item><a id=m-sec
                 href=http://google.brand.edgar-online.com?sym=ACRX >SEC Filings</a> - <font color="#6F6F6F">EDGAR Online</font></div>
<div class=item><a id=m-hold
                 href=http://moneycentral.msn.com/investor/invsub/ownership/ownership.asp?Symbol=ACRX >Major Holders</a> - <font color="#6F6F6F">MSN Money</font></div>
<div class=item><a id=m-research
                 href=https://commerce.us.reuters.com/purchase/advancedSearch.do?symbol=ACRX.O&rpc=68 >Research Reports</a> - <font color="#6F6F6F">Reuters</font></div>
<div class=item><a href="
  //groups.google.com/forum/?hl=en#!forum/google.finance.9390385
" >Discussion Group</a> - <font color="#6F6F6F">Google Finance</font></div>
</div>
</div>
</div>
<div class=g-unit>
<div id=top-section class="g-c sfe-break-right">
<div id=chart-section>
<div>
<div id=compare-bar-wrapper class=id-compare-bar-wrapper>
<div id=compare-bar class="id-compare-bar g-section">
</div>
</div>
<div id=chart_anchor class=id-chart_anchor></div>
<div class=id-chart-footer>
<div class="g-section g-tpl-67-33 g-split sfe-break-bottom-8 overflow-floatfix">
<div class="g-unit g-first"><div class="id-chart-footer-links hide">
<span class=settings-link>Settings</span> |
<span class=plotfeeds-link>Plot&nbsp;feeds</span> |
<span class=technicals-link>Technicals</span> |
<span style="white-space:nowrap;">
<img width="16" hight="9" alt="Link to chart icon."
            class="linktochart-img SP_link"
            src="/finance/s/m4C5KaofCbA/images/cleardot.gif" />
<span class=linktochart-link>
Link to this view</span>
</span>
</div></div>
<div class="g-unit">
<span class="chart-dis">Volume delayed by 15 mins.
</span>
</div>
</div>
</div>
<script>
var _minZoomDays = 1;
var _minZoomDaysNoIntraDay = _minZoomDays;
var _timeZoneOffset = '-18000';
_chartConfigObject = {};
_chartConfigObject.hasVolume = _displayVolume;
_chartConfigObject.hasNews = true;
_chartConfigObject.hasExtendedHours = true;
_chartConfigObject.hasDefaultZoomSetting = true;
_chartConfigObject.hasVerticalScaleSetting = true;
_chartConfigObject.displayVolume = 'true';
_chartConfigObject.displayNewsPins = 'true';
_chartConfigObject.displayDividends = 'true';
_chartConfigObject.displaySplits = 'true';
_chartConfigObject.displayExtendedHours = 'false';
_chartConfigObject.enableCustomDateEntry = true
_chartConfigObject.defaultZoomDays = '3';
_chartConfigObject.snapping = false;
_chartConfigObject.verticalScaling = 'maximized';
_chartConfigObject.sparklineType = 'dynamic';
// set _minZoomDays and _minZoomDaysNoIntraDay in each page before emit the
// chart to passing the value to chart, otherwise default value will be use.
_chartConfigObject.minZoomDaysNormal = _minZoomDays;
_chartConfigObject.minZoomDaysNoIntraDay = _minZoomDaysNoIntraDay;
_chartConfigObject.enableIndicator = true;
_chartConfigObject.companyId = '9390385';
_chartConfigObject.enableRealtimeChart = true;
_chartConfigObject.isMarketOpenState = 0;
_chartConfigObject.stateRemainingMinutes = 735;
_chartConfigObject.delayedMinutes = 0;
_chartConfigObject.delayedMinutes = Math.max(
_chartConfigObject.delayedMinutes,
15);
_chartConfigObject.enableChartTypeSetting = true;
_chartConfigObject.lineStyle = 'IntervalBasedLine';
_chartConfigObject.defaultInterval = '86400';
_chartConfigObject.enableIndicatorSetting = true;
_chartConfigObject.biasSetting = '';
_chartConfigObject.emaSetting = '';
_chartConfigObject.kdjSetting = '';
_chartConfigObject.macdSetting = '';
_chartConfigObject.rsiSetting = '';
_chartConfigObject.smaSetting = '';
_chartConfigObject.vmaSetting = '';
_chartConfigObject.cciSetting = '';
_chartConfigObject.williamsPercentRSetting = '';
_chartConfigObject.bollingerBandsSetting = '';
_chartConfigObject.fastStochasticSetting = '';
_chartConfigObject.slowStochasticSetting = '';
_chartConfigObject.expandButtonEnabled = true;
_chartConfigObject.companyCurrency = 'USD';
_chartConfigObject.displayDividendsUnits = 'true';
var configStringFromCookie = '{}';
var configString = unescape(configStringFromCookie);
var obj = eval('(' + configString + ')');
for (var attribute in obj) {
_chartConfigObject[attribute] = obj[attribute];
}
_external_target = "";
_emitFlashChart(
"/finance/s/ytAiJsp2Tzo/chart9.swf?hl=en&gl=us",
_ticker, _chartConfigObject,"http:\x2F\x2Fwww.google.com:80");
</script>
<noscript>
<div id=image_chart style="display:block;">
<table>
<tr><td class=itxt align=left>
</td></tr>
<tr><td>
<img alt="Chart." src="/finance/getchart?q=ACRX&x=NASD&p=3d&i=240" width="500" height="322">
</td></tr>
</table>
</div>
</noscript>
<div style="height:1em;"></div>
</div>
</div>
<div class=ad-target2-wrapper>
<div id=ad-label2 class=invisible>Advertisement</div>
<div id=ad-target2 class=id-ad-target2></div>
</div>
</div>
<div class="g-c sfe-break-right">
<div id=related class="id-related hide">
<div class=hdg>
<div class=float>
<h3>Related companies</h3>
</div>
</div>
<div>
<div class="g-section g-tpl-50-50 g-split gf-control">
<div class="g-unit g-first">
Show:
<select id=related-select class=id-related-select>
<option value=mrq >
Most Recent Quarter
</option>
<option value=mra selected>
Most Recent Annual
</option>
</select>
</div>
<div class=g-unit>
<span class="id-related-edit-col linkbtn">Add or remove columns</span>
<button class=id-related-save style="display:none">Save changes</button>
<button class=id-related-cancel style="display:none">Cancel</button>
</div>
</div>
</div>
<div class="id-related-table gf-table-scroll-x"
       style="padding-bottom:15px;">
</div>
<div class=sfe-section>
<div class="g-section g-tpl-50-50 g-split">
<div class="g-unit g-first">Sector: <a id=sector href="?catid=us-64715132" >Healthcare</a> &gt; Industry: <a href="?catid=us-52981623" >Biotechnology and Drugs</a>
</div><div class=g-unit>
<a href="http://www.reveredata.com/about/products/reports/more-from-revere.html" >More from Revere Data &raquo;</a>
</div>
</div>
</div>
</div>
<div id=reorder class=id-reorder><div class=mid-reorder>
<div id=blogs-section
>
</div>
<div id=discussions-section
>
</div><script>_tck('aft');</script>
<div id=summary-section
>
<div id=summary>
<div class=hdg><div class=float>
<h3>Description</h3></div>
<div class="gf-reorder-btn SP_menu_button"></div>
</div>
<div class=sfe-section>
<div class=companySummary>
AcelRx Pharmaceuticals, Inc. is a development-stage company. The Company is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. It has completed Phase 2 clinical development for two additional product candidates, the Sufentanil NanoTab BTP Management System, or ARX-02, for the treatment of cancer breakthrough pain (BTP), and the Sufentanil/Triazolam NanoTab, or ARX-03, designed to provide mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician�s office. The Company is preparing to initiate two Phase 3 clinical trials for its product candidate, the Sufentanil NanoTab PCA System, or ARX-01. ARX-02 is a product candidate for the treatment of cancer patients who suffer from breakthrough pain. ARX-03 Sufentanil/Triazolam NanoTab is a single, fixed-dose sublingual product candidate.
<div class=sfe-break-top>
<a id=m-rprofile href="http://stocks.us.reuters.com/stocks/fullDescription.asp?rpc=66&symbol=ACRX.O" >
More from Reuters &raquo;
</a></div>
</div>
</div>
</div>
</div>
<div id=mgmt-section
>
<div id=management style="margin-bottom:1.5em;">
<div class=hdg><div class=float>
<h3>Officers and directors</h3></div>
<div class="gf-reorder-btn SP_menu_button"></div>
</div>
<div class=sfe-section>
<table class=id-mgmt-table width=100%><tbody>
<tr >
<td class="p linkbtn">Thomas A. Schreck
<td class=i>
<td class=t>Chairman of the Board
</tr>
<tr style="display:none;">
<td><img width=1 height=1 border=0 align=right>
<td class=i>
<td class=t>
Age: 54<br>
<a class=e-p href="http://www.reuters.com/finance/stocks/officerProfile?symbol=ACRX.O&officerId=1545101" >Bio&nbsp;&amp;&nbsp;Compensation</a>&nbsp;-&nbsp;<font color="#606060">Reuters</font><br>
<tr class=grey-top>
<td class="p linkbtn">Richard A. King
<td class=i>
<td class=t>President, Chief Executive Officer, Director
</tr>
<tr style="display:none;">
<td><img width=1 height=1 border=0 align=right>
<td class=i>
<td class=t>
Age: 47<br>
<a class=e-p href="http://www.reuters.com/finance/stocks/officerProfile?symbol=ACRX.O&officerId=1545103" >Bio&nbsp;&amp;&nbsp;Compensation</a>&nbsp;-&nbsp;<font color="#606060">Reuters</font><br>
<tr class=grey-top>
<td class="p linkbtn">James H. Welch
<td class=i>
<td class=t>Chief Financial Officer
</tr>
<tr style="display:none;">
<td><img width=1 height=1 border=0 align=right>
<td class=i>
<td class=t>
Age: 54<br>
<a class=e-p href="http://www.reuters.com/finance/stocks/officerProfile?symbol=ACRX.O&officerId=1545112" >Bio&nbsp;&amp;&nbsp;Compensation</a>&nbsp;-&nbsp;<font color="#606060">Reuters</font><br>
<tr class=grey-top>
<td class="p linkbtn">Pamela P. Palmer M.D., Ph.D.
<td class=i>
<td class=t>Chief Medical Officer, Director
</tr>
<tr style="display:none;">
<td><img width=1 height=1 border=0 align=right>
<td class=i>
<td class=t>
Age: 49<br>
<a class=e-p href="http://www.reuters.com/finance/stocks/officerProfile?symbol=ACRX.O&officerId=1545104" >Bio&nbsp;&amp;&nbsp;Compensation</a>&nbsp;-&nbsp;<font color="#606060">Reuters</font><br>
<tr class=grey-top>
<td class="p linkbtn">Badri N. Dasu
<td class=i>
<td class=t>Chief Engineering Officer
</tr>
<tr style="display:none;">
<td><img width=1 height=1 border=0 align=right>
<td class=i>
<td class=t>
Age: 48<br>
<a class=e-p href="http://www.reuters.com/finance/stocks/officerProfile?symbol=ACRX.O&officerId=1545116" >Bio&nbsp;&amp;&nbsp;Compensation</a>&nbsp;-&nbsp;<font color="#606060">Reuters</font><br>
<tr class=grey-top>
<td class="p linkbtn">Lawrence G. Hamel
<td class=i>
<td class=t>Chief Development Officer
</tr>
<tr style="display:none;">
<td><img width=1 height=1 border=0 align=right>
<td class=i>
<td class=t>
Age: 60<br>
<a class=e-p href="http://www.reuters.com/finance/stocks/officerProfile?symbol=ACRX.O&officerId=1545113" >Bio&nbsp;&amp;&nbsp;Compensation</a>&nbsp;-&nbsp;<font color="#606060">Reuters</font><br>
<tr class=grey-top>
<td class="p linkbtn">Mark G. Edwards
<td class=i>
<td class=t>Independent Director
</tr>
<tr style="display:none;">
<td><img width=1 height=1 border=0 align=right>
<td class=i>
<td class=t>
Age: 54<br>
<a class=e-p href="http://www.reuters.com/finance/stocks/officerProfile?symbol=ACRX.O&officerId=1636439" >Bio&nbsp;&amp;&nbsp;Compensation</a>&nbsp;-&nbsp;<font color="#606060">Reuters</font><br>
<tr class=grey-top>
<td class="p linkbtn">Stephen J. Hoffman M.D., Ph.D.
<td class=i>
<td class=t>Independent Director
</tr>
<tr style="display:none;">
<td><img width=1 height=1 border=0 align=right>
<td class=i>
<td class=t>
Age: 58<br>
<a class=e-p href="http://www.reuters.com/finance/stocks/officerProfile?symbol=ACRX.O&officerId=1545107" >Bio&nbsp;&amp;&nbsp;Compensation</a>&nbsp;-&nbsp;<font color="#606060">Reuters</font><br>
<tr class=grey-top>
<td class="p linkbtn">Guy P. Nohra
<td class=i>
<td class=t>Independent Director
</tr>
<tr style="display:none;">
<td><img width=1 height=1 border=0 align=right>
<td class=i>
<td class=t>
Age: 51<br>
<a class=e-p href="http://www.reuters.com/finance/stocks/officerProfile?symbol=ACRX.O&officerId=1545108" >Bio&nbsp;&amp;&nbsp;Compensation</a>&nbsp;-&nbsp;<font color="#606060">Reuters</font><br>
<tr class=grey-top>
<td class="p linkbtn">Howard B. Rosen
<td class=i>
<td class=t>Independent Director
</tr>
<tr style="display:none;">
<td><img width=1 height=1 border=0 align=right>
<td class=i>
<td class=t>
Age: 53<br>
<a class=e-p href="http://www.reuters.com/finance/stocks/officerProfile?symbol=ACRX.O&officerId=1545109" >Bio&nbsp;&amp;&nbsp;Compensation</a>&nbsp;-&nbsp;<font color="#606060">Reuters</font><br>
</table>
<div class=gb>
<a href="http://stocks.us.reuters.com/stocks/officersDirectors.asp?symbol=ACRX.O&WTmodLOC=C4-Officers-5" >
Full list on Reuters &raquo;</a></div>
</div>
</div>
</div>
</div></div>
</div>
</div>
</div>
</div>
</div></div></div></div></div><div id=gf-foot><div class=fjfe-footer-links>Google Finance Beta available in: <a href="http://www.google.com.hk/finance" class="fjfe-edition-link">Hong Kong</a> - <a href="http://www.google.ca/finance" class="fjfe-edition-link">Canada</a> - <a href="http://www.google.com/finance" class="fjfe-edition-link">U.S.</a> - <a href="http://www.google.com.hk/finance?hl=zh-CN" class="fjfe-edition-link">China</a> - <a href="http://www.google.co.uk/finance" class="fjfe-edition-link">U.K.</a></div><p class=fjfe-footer-disclaimer>Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.<br>To see all exchange delays, please <a href="http://www.google.com/intl/en/help/stock_disclaimer.html" class="fjfe-secondary-link fjfe-no-sticky-params"> see disclaimer</a>.</p><div class=fjfe-footer-links>&copy;2012 Google - <a href="http://www.google.com?hl=en">Google Home</a> - <a href="http://googlefinanceblog.blogspot.com">Blog</a> - <a href="http://support.google.com/finance?hl=en">Help</a> - <a href="http://support.google.com/finance?ctx=report&hl=en&exch=NASDAQ&sym=ACRX">Report a Problem</a> - <a href="http://www.google.com/intl/en/privacy.html">Privacy Policy</a> - <a href="http://www.google.com/accounts/TOS?hl=en&loc=us">Terms of Service</a></div></div>
<script>
var _chartConfigObject;
var _cleardot;
var _companyName;
var _eventid = null;
var _expid;
var _external_target;
var _minZoomDays;
var _minZoomDaysNoIntraDay;
var _prefs;
var _ticker;
var _urlSuffix;
_setStickyUrlParams("");
if (_s_Store) {
_s_Store._allowMatchAdvancedSearch = true;
var _fieldToDisplayNameMap = {GrossMargin:"Gross margin&nbsp;(%)",Return1Week:"1w return",Return156Week:"156w return",NextYearEPS:"Next year EPS",LTDebtToAssetsYear:"LT debt/assets (Recent&nbsp;yr)&nbsp;(%)",RevenueGrowthRate5Years:"5y revenue growth rate",EarningsAfterTaxes:"Earnings after taxes",DividendPerShare:"Div per share",MarketCap:"Market cap",NetProfitMarginPercent:"Net profit margin&nbsp;(%)",Float:"Float",EarningsBeforeTaxes:"Earnings before taxes",QuotePercChange:"Quote change&nbsp;(%)",TotalDebtToEquityYear:"Total debt/equity (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToCapitalQuarter:"Total debt/capital (Recent&nbsp;qtr)&nbsp;(%)",LTDebtToCapitalQuarter:"LT debt/capital (Recent&nbsp;qtr)&nbsp;(%)",EPSGrowthRate10Years:"10y EPS growth rate",Beta:"Beta",ReturnOnAssetsPTM:"Return on assets (PTM)&nbsp;(%)",CapitalGain:"Capital gain",BetaDown:"Beta down from RAS",IncomeDividend:"Income dividend",RevenueGrowthRate10Years:"10y revenue growth rate",MarketCapShareBasis:"Market cap share basis",IAD:"Div rate indicated annual",Return4Week:"4w return",Price150DayAverage:"150d avg price",EPSGrowthRate5Years:"5y EPS growth rate",ReturnOnAssetsTTM:"Return on assets (TTM)&nbsp;(%)",TotalDebtToAssetsYear:"Total debt/assets (Recent&nbsp;yr)&nbsp;(%)",Volume:"Volume",DividendRecentQuarter:"Div recent quarter",CurrentRatioYear:"Current ratio",Low52Week:"52w low",ExpenseRatio:"Expense ratio",Price13WeekPercChange:"13w&nbsp;price change&nbsp;(%)",Price1DayPercChange:"1d&nbsp;price change&nbsp;(%)",ReturnOnEquity5Years:"Return on equity (5&nbsp;yr&nbsp;avg)&nbsp;(%)",TotalDebtToCapitalYear:"Total debt/capital (Recent&nbsp;yr)&nbsp;(%)",TotalDebtToAssetsQuarter:"Total debt/assets (Recent&nbsp;qtr)&nbsp;(%)",NavChange:"Nav change",OperatingMargin:"Operating margin&nbsp;(%)",DPSRecentYear:"Div per share (Recent&nbsp;yr)",ANI:"Earnings after taxes (Recent&nbsp;yr)",AverageVolume:"Average volume",High52Week:"52w high",Return13Week:"13w return",PriceToCashFlowPerShare:"Price to cash flow per share",ATAXRATE:"Tax rate (Recent&nbsp;yr)",Price26WeekPercChange:"26w&nbsp;price change&nbsp;(%)",QuoteChange:"Quote change",NetIncomeChangePerc:"Net income change&nbsp;(%)",ReturnOnInvestment5Years:"Return on investment (5&nbsp;yr&nbsp;avg)&nbsp;(%)",PE:"P/E ratio",ReturnOnInvestmentYear:"Return on investment (Recent&nbsp;yr)&nbsp;(%)",Price200DayAverage:"200d avg price",DividendNextQuarter:"Div next quarter",EBITD:"EBITDA",PriceYTDPercChange:"YTD&nbsp;price change&nbsp;(%)",ReturnOnInvestmentTTM:"Return on investment (TTM)&nbsp;(%)",NavChangePercent:"Nav change&nbsp;(%)",EBITDMargin:"EBITDA margin&nbsp;(%)",LTDebtToEquityQuarter:"LT debt/equity (Recent&nbsp;qtr)&nbsp;(%)",BetaRAS:"Beta from RAS",PriceSales:"Price to sales",NetAssets:"Net assets",ReturnOnEquityTTM:"Return on equity (TTM)&nbsp;(%)",CashPerShareYear:"Cash/share",ReturnOnAssets5Years:"Return on assets (5&nbsp;yr&nbsp;avg)&nbsp;(%)",ReturnDay:"1d return",Return52Week:"52w return",ForwardPE1Year:"1y fwd P/E",NetIncomeGrowthRate5Years:"5y net income growth rate",DividendYield:"Div yield&nbsp;(%)",Dividend:"Div from cash flow",BetaUp:"Beta up from RAS",LTDebtToCapitalYear:"LT debt/capital (Recent&nbsp;yr)&nbsp;(%)",nprice:"Price from RAS",Return260Week:"260w return",ReturnOnEquityQuarter:"Return on equity (Recent&nbsp;qtr)&nbsp;(%)",ACOGS:"Cost of goods sold",LTDebtToAssetsQuarter:"LT debt/assets (Recent&nbsp;qtr)&nbsp;(%)",PriceToBook:"Price to book",LTDebtToEquityYear:"LT debt/equity (Recent&nbsp;yr)&nbsp;(%)",ReturnYTD:"Return YTD",ReturnOnEquityYear:"Return on equity (Recent&nbsp;yr)&nbsp;(%)",ReturnOnAssetsQuarter:"Return on assets (Recent&nbsp;qtr)&nbsp;(%)",TotalDebtToEquityQuarter:"Total debt/equity (Recent&nbsp;qtr)&nbsp;(%)",NavPrior:"Nav prior",AINTCOV:"Interest coverage",EPS:"EPS",ReturnOnInvestmentQuarter:"Return on investment (Recent&nbsp;qtr)&nbsp;(%)",QuoteLast:"Last price",Price50DayAverage:"50d avg price",Price4WeekPercChange:"4w&nbsp;price change&nbsp;(%)",ReturnOnAssetsYear:"Return on assets (Recent&nbsp;yr)&nbsp;(%)",MarketCapRAS:"Mkt cap from RAS",Price52WeekPercChange:"52w&nbsp;price change&nbsp;(%)",ShortInterestRatioPercent:"Short interest ratio&nbsp;(%)",InstitutionalPercentHeld:"Institutional percent held",BookValuePerShareYear:"Book value/share",ReturnOnEquityPTM:"Return on equity (PTM)&nbsp;(%)"};
_s_Store._asStore._addStrings(_fieldToDisplayNameMap);
}
if (_s_Store) {
_s_Store._allowMultipleInBox = true;
}
_regOnLoad(onCompanyLoad);
</script>
</div></div><script>var googlefinance = {i: ["f.b.id","",,0,"",0,,["f.b.cf","qNG2-4Cp47I.en_US.",0]
,[]
,0]
};</script></body></html>